Australia's largest stock trading and investment forum Australia's #1 stock forum

RECCE PHARMACEUTICALS LTD

3.57%

29.0¢

Market Cap $72.42M

Healthcare Biotechnology

An Emerging Global Leader in the New Generation of Anti-Infective Therapies. Recce... An Emerging Global Leader in the New Generation of Anti-Infective Therapies. Recce Pharmaceuticals Ltd (ASX:RCE) is an Australian based globally-focussed, biotechnology company engaged in the development and commercialisation of a new class of synthetic anti-infectives.More

Corporate Spotlight

An Emerging Global Leader in the New Generation of Anti-Infective Therapies. Recce Pharmaceuticals Ltd (ASX:RCE) is an Australian based globally-focussed, biotechnology company engaged in the development and commercialisation of a new class of synthetic anti-infectives.
View the full Corporate Spotlight

Recce accelerates commercialisation

Latest Threads

Tag

Subject

Ann: Investor Webinar Recording Available

21:00

4

561

21:00

Last post BelowAverage

4

561

Ann: Ceasing to be a substantial holder from MQG

18:08

0

146

18:08

Last post

ASX News

0

146

Directors Taking Entitlements… Insider Confidence?

10:18

4

1.3K

10:18

Last post bigwilllly

4

1.3K

Recce adds 20 more people to trial for R327G foot gel

22/04/25

0

201

22/04/25

Last post ASX Insights

0

201

Ann: Phase II Clinical Trial Receives Additional Approval for DFI

22/04/25

3

815

22/04/25

Last post BelowAverage

3

815

Ann: Entitlement Offer - Notification to Ineligible Shareholders

22/04/25

0

211

22/04/25

Last post

ASX News

0

211

Ann: Entitlement Offer - Offer Booklet and Access Letter

22/04/25

0

196

22/04/25

Last post

ASX News

0

196

Ann: Placement Settlement Completed

17/04/25

1

455

17/04/25

Last post Gitmo

1

455

Ann: Cleansing Notice

17/04/25

0

200

17/04/25

Last post

ASX News

0

200

Ann: Application for quotation of securities - RCE

17/04/25

0

199

17/04/25

Last post

ASX News

0

199

Ann: Placement and Entitlement Offer to Fund Phase III Trials

15/04/25

19

7.6K

15/04/25

Last post bedger

19

7.6K

Ann: RCE Investor Webinar Presentation

15/04/25

0

338

15/04/25

Last post

ASX News

0

338

Recce to raise $15.8M in trial funds through placement, entitlement offer

10/04/25

0

305

10/04/25

Last post ASX Insights

0

305

Ann: Equity Raising Presentation

10/04/25

0

316

10/04/25

Last post

ASX News

0

316

Ann: Cleansing Notice - Entitlement Offer

10/04/25

0

205

10/04/25

Last post

ASX News

0

205

Ann: Proposed issue of securities - RCE

10/04/25

0

225

10/04/25

Last post

ASX News

0

225

See All Discussions

Corporate Spotlight

ABOUT US

Timeline

Ceasing to be a substantial holder from MQG
23 Apr 17:48	Share

Investor Webinar Recording Available
23 Apr 12:19	Share

Entitlement Offer - Notification to Ineligible Shareholders
22 Apr 10:09	Share

Entitlement Offer - Offer Booklet and Access Letter
22 Apr 10:07	Share

Phase II Clinical Trial Receives Additional Approval for DFI
22 Apr 09:57	Share

Cleansing Notice
17 Apr 10:42	Share

Placement Settlement Completed
17 Apr 10:34	Share

Application for quotation of securities - RCE
17 Apr 10:28	Share

RCE Investor Webinar Presentation
15 Apr 13:46	Share

Equity Raising Presentation
10 Apr 10:11	Share

Cleansing Notice - Entitlement Offer
10 Apr 09:55	Share

Placement and Entitlement Offer to Fund Phase III Trials
10 Apr 09:44	Share

Proposed issue of securities - RCE
10 Apr 09:37	Share

Becoming a substantial holder from MQG
28 Mar 16:43	Share

RCE Corporate Presentation
20 Mar 09:44	Share

Key Opinion Leader Presentation
03 Mar 10:08	Share

RCE Clinical Milestones Investor Webinar
28 Feb 12:15	Share

Appendix 4D and Interim Financial Report
28 Feb 08:50	Share

Japan Patent Allowance for RECCE Anti-Infectives
26 Feb 10:12	Share

Positive Phase II Data from Clinical Trial of R327 Gel
17 Feb 09:24	Share

Trading Halt
13 Feb 11:56	Share

Pause in Trading
13 Feb 11:31	Share

Correction to Appendix 4C and Quarterly Activities Report
06 Feb 11:29	Share

Quarterly Activities/Appendix 4C Cash Flow Report
31 Jan 17:26	Share

Patient Dosing Complete in Phase II ABSSSI Trial of R327G
21 Jan 09:57	Share

Regulatory Approval for Registrational Phase 3 R327G Trial
09 Dec 09:05	Share

Trading Halt
05 Dec 09:21	Share

Presentation - Ord Minnett Biotech & MedTech Conference
28 Nov 12:42	Share

Australia Patent Granted for RECCE Anti-Infectives
26 Nov 08:37	Share

Change of Director's Interest Notices
21 Nov 19:31	Share

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 29.0¢		Change 0.010(3.57%)		Mkt cap ! $72.42M

Open	High	Low	Value	Volume
29.0¢	29.0¢	28.0¢	$33.07K	114.5K

Buyers (Bids)

No.	Vol.	Price($)
1	10000	28.5¢

Sellers (Offers)

Price($)	Vol.	No.
29.0¢	26762	1

View Market Depth

No.	Vol.	Price($)
1	10000	0.285
5	40307	0.280
2	12269	0.275
3	17000	0.270
2	39739	0.265

Price($)	Vol.	No.
0.290	26762	1
0.295	100000	1
0.300	135768	2
0.305	3278	1
0.320	13125	2

Last trade - 16.10pm 23/04/2025 (20 minute delay)


Last 28.5¢			Change 0.010 ( 1.10 %)
Open	High		Low	Volume
28.8¢	29.0¢		28.0¢	37733
Last updated 15.57pm 23/04/2025 ?

RCE (ASX) Chart